Homology Medicines Inc
|Market Cap (Intraday)||66.19M|
|2yr Forward PE||N/A|
Homology Medicines Inc Stock, NASDAQ:FIXX
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA.